The Omega-3 Industry Leader, Croda Health Care, selects
Neptune Technologies’ Ingredients for New Essentially Brand
---Intense R&D generates 5 innovative Essentially products for multiple health applications---
---Launch scheduled for April 2008 in the United States and May 2008 in Europe---
Laval, QC, CANADA and East Yorkshire, UNITED KINGDOM – April 2 nd , 2008 – Neptune Technologies & Bioressources
Inc. and Croda Health Care, the worldwide leader in innovative specialty ingredients for nutritional and pharmaceutical health
care markets, today announced the completion of a strategic commercialization alliance for North America and Europe. After an
intensive joint research and development phase, both companies are looking forward to launching the Essentially™ brand
comprised of five distinct products containing different combinations of both companies’ clinically proven ingredients.
Croda Health Care is recognized as the leading industry manufacturer of innovative omega-3 products; its Incromega TM
product range is a cutting-edge generation of omega-3 marine oil concentrates that offer enhanced potency, purity and efficacy.
Through the combination of Neptune marine phospholipids and Croda’s Incromega™ ingredients, the Essentially™ product
range is synergistically enhanced to target maximum consumer health performance. The omega-3 fatty acids EPA
(eicosapentaenoic acid) and DHA (docosahexaenoic acid) are particularly beneficial for the healthy functioning of the heart,
brain and nervous system. Each Essentially™ product is specifically designed to deliver optimum levels of EPA/ DHA
functionalized marine phospholipids, representing a new level of excellence in omega-3 standards.
The launch of the Essentially™ brand is scheduled at the Supply-Side East Tradeshow in Secaucus, New Jersey on April 28-30,
2008 for North America. The European launch is planned at the Vitafoods Convention in Geneva, Switzerland on May 6-8, 2008.
Thierry Houillon, Vice President of Nutraceuticals of Neptune said th